bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.12.05.627123

Blood flow simulation and uncertainty quantification in extensive microvascular networks: Application to brain cortical networks

Abstract

0.1Spatially resolved simulation models of microcirculatory blood flow facilitate a detailed understanding of microcirculatory phenomena at the micrometer scale by capturing heterogeneity in blood flow. These models combine physical laws, empirical descriptions of the bloods complex rheological behavior, and in-vivo/ex-vivo imaging of the microvasculature. However, imaged areas often only partially represent self-contained tissue regions, leading to numerous vessels crossing boundaries and strongly influencing simulated blood flows through imposed boundary conditions. Selecting appropriate boundary conditions is challenging due to the heterogeneity of pressures and blood flows, resulting in significant uncertainties. This study addresses two key methodological aspects of spatially resolved blood flow simulations: selecting appropriate boundary conditions and quantifying the impact of boundary condition uncertainties on simulated hemodynamic variables. An adaptive method for assigning appropriate pressure boundary conditions is proposed and rigorously evaluated in extensive brain cortical networks against reference data from an established blood flow simulation model. A probabilistic approach is adopted to assess the impact of boundary condition uncertainties on blood flow simulations. The adaptive method is further integrated into a Bayesian calibration framework, inferring distributions over thousands of unknown pressure boundary conditions and providing uncertainty estimates for blood flow simulations. The adaptive method, which is straightforward to implement and scales well with extensive microvascular networks, produces hemodynamic simulations consistent with reference data, yielding depth-dependent pressure profiles and layer-wise capillary blood flow profiles consistent with previous studies. These phenomena are demonstrated to generalize also to biphasic blood flow simulation models incorporating in-vivo viscosity formulations. The uncertainty analysis further reveals a novel spatially heterogeneous and depth-dependent pattern in blood flow uncertainty. It is anticipated that the adaptive method for pressure boundary conditions will be useful in future applications of both forward and inverse blood flow modeling, and that uncertainty quantification will be valuable in complementing hemodynamic predictions with associated uncertainties. 0.2 Author summaryThis research focuses on improving the accuracy of blood flow simulations in tiny blood vessels, known as microvascular networks. These simulations help understand how blood moves through the smallest vessels in the body, crucial for studying various health conditions. However, accurately simulating blood flow is challenging because imaged areas often dont capture entire tissue regions, leading to uncertainties. I developed an adaptive method for setting boundary conditions in these simulations. Due to its adaptive nature, the method can be applied to microvascular networks from various types of tissue, making it broadly applicable. This method was tested extensively using data from brain cortical networks and produced reliable results, proving its validity and scalability to extensive networks. Additionally, probabilistic approaches were used to assess how uncertainties in boundary conditions affect the simulations. A key contribution is the integration of the adaptive method into a Bayesian calibration framework. This framework assimilates simulations with observations and infers distributions over thousands of unknown boundary conditions, providing uncertainty estimates for blood flow simulations. The proposed adaptive method and uncertainty analysis are expected to be valuable for future studies of microvascular blood flow, improving both the accuracy of the simulations and the understanding of the associated uncertainties.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Rasmussen, P. M.. 2024-12-10. Blood flow simulation and uncertainty quantification in extensive microvascular networks: Application to brain cortical networks. https://doi.org/10.1101/2024.12.05.627123

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗